Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology

The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole

(2013) Jason N. Barreto et al.   AMERICAN JOURNAL OF HEMATOLOGY

Posaconazole vs. fluconazole as invasive fungal infection prophylaxis in China: a multicenter, randomized, open-label study

(2013) Yang Shen et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Posaconazole prophylaxis - impact on incidence of invasive fungal disease and antifungal treatment in haematological patients

(2013) Lisa Peterson et al.   MYCOSES

Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Micafungin versus Itraconazole for Prophylaxis of Invasive Fungal Infections in Patients undergoing Hematopoietic Stem Cell Transplant

(2012) Xiaojun Huang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Comparison of Posaconazole Versus Weekly Amphotericin B Lipid Complex for the Prevention of Invasive Fungal Infections in Hematopoietic Stem-Cell Transplantation

(2012) Anne-Marie Chaftari et al.   TRANSPLANTATION

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation

(2011) David I. Marks et al.   BRITISH JOURNAL OF HAEMATOLOGY

A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study)

(2011) C. Cattaneo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Prophylactic Application of Nebulized Liposomal Amphotericin B in Hematologic Patients with Neutropenia

(2011) Annette Hullard-Pulstinger et al.   ONKOLOGIE

Efficacy, Safety, and Breakthrough Infections Associated with Standard Long-Term Posaconazole Antifungal Prophylaxis in Allogeneic Stem Cell Transplantation Recipients

(2010) Drew J. Winston et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

(2010) J. R. Wingard et al.   BLOOD

Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation

(2010) I Sánchez-Ortega et al.   BONE MARROW TRANSPLANTATION

Prophylaxis and Treatment of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Results of a Consensus Process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO)

(2009) Corrado Girmenia et al.   CLINICAL INFECTIOUS DISEASES

Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome

(2009) Gloria N. Mattiuzzi et al.   SUPPORTIVE CARE IN CANCER

Aerosolized Liposomal Amphotericin B for the Prevention of Invasive Pulmonary Aspergillosis during Prolonged Neutropenia: A Randomized, Placebo‐Controlled Trial

(2008) Bart J. Rijnders et al.   CLINICAL INFECTIOUS DISEASES

Patients at High Risk of Invasive Fungal Infections

(2008) Maria J G T Rüping et al.   DRUGS

Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology

(2008) O. A. Cornely et al.   HAEMATOLOGICA

Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation

(2008) Yasushi Hiramatsu et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY